69 Afatinib versus gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations: results of the global, randomised, open-label, phase IIb trial LUX-Lung 7. (January 2016)

Record Type:
Journal Article
Title:
69 Afatinib versus gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations: results of the global, randomised, open-label, phase IIb trial LUX-Lung 7. (January 2016)
Main Title:
69 Afatinib versus gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations: results of the global, randomised, open-label, phase IIb trial LUX-Lung 7
Authors:
O'Byrne, K.J.
Park, K.
Tan, E.
Zhang, L.
Hirsh, V.
Boyer, M.
Yang, J.C.
Mok, T.
Kim, M.
Massey, D.
Zazulina, V.
Paz-Ares, L.
Abstract:
Is Part Of:
Lung cancer. Volume 91(2016)Supplement 1
Journal:
Lung cancer
Issue:
Volume 91(2016)Supplement 1
Issue Display:
Volume 91, Issue 1 (2016)
Year:
2016
Volume:
91
Issue:
1
Issue Sort Value:
2016-0091-0001-0000
Page Start:
S25
Page End:
Publication Date:
2016-01
Subjects:
Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:
http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0169-5002(16)30086-1 ↗
Languages:
English
ISSNs:
0169-5002
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
2878.xml